Victor Sandor
2017
In 2017, Victor Sandor earned a total compensation of $2.5M as Chief Medical Officer at Array BioPharma, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $232,225 |
|---|---|
| Option Awards | $1,369,925 |
| Salary | $462,000 |
| Stock Awards | $396,764 |
| Other | $11,359 |
| Total | $2,472,273 |
Sandor received $1.4M in option awards, accounting for 55% of the total pay in 2017.
Sandor also received $232.2K in non-equity incentive plan, $462K in salary, $396.8K in stock awards and $11.4K in other compensation.
Rankings
In 2017, Victor Sandor's compensation ranked 4,478th out of 14,666 executives tracked by ExecPay. In other words, Sandor earned more than 69.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,478 out of 14,666 | 70th |
Division Manufacturing | 1,578 out of 5,772 | 73rd |
Major group Chemicals And Allied Products | 454 out of 2,075 | 78th |
Industry group Drugs | 349 out of 1,731 | 80th |
Industry Pharmaceutical Preparations | 276 out of 1,333 | 79th |
Source: SEC filing on September 13, 2017.
Sandor's colleagues
We found five more compensation records of executives who worked with Victor Sandor at Array BioPharma in 2017.